Table 3.
Anti-microbial susceptibility profile of 26 E. coli isolates.
| Antibiotic Group | Antibiotic | Disc Potency Mg/disc | Number of Resistant Strains (%) |
|---|---|---|---|
| Aminoglycosides | Streptomycin | 10 µg | 18(69.2%) |
| Amikacin | 30 µg | 20(76.9%) | |
| Tetracyclines | Tetracycline | 30 µg | 26(100%) |
| Doxycycline | 30 µg | 13(50%) | |
| Quinolones | Nalidexic acid | 30 μg | 17 (65.4%) |
| Norfloxacin | 10ug | 19 (73.1%) | |
| Ciprofloxacin | 5 μg | 14 (53.8%) | |
| Levofloxacin | 5 μg | 13(50%) | |
| β-Lactams | Ampicillin | 10ug | 26(100%) |
| Amoxicillin | 30 μg | 26(100%) | |
| Diaminopyrimidine | Trimethoprim | 10 μg | 17 (65.4%) |